ALLR
BULLISH, It's supper undervalued. $19-$20 cash on hand, 1 million float, 1.4 million O/S, The company confirmed there will be zero need to dilute via ATM offering. They recently got granted EPO patent, FDA news should be out very soon.
2 gaps need to filled on the way up, keep an eye on it. with $19-$20 million cash on hand, a price target of $10 is fairly valued even without FDA granted.
2 gaps need to filled on the way up, keep an eye on it. with $19-$20 million cash on hand, a price target of $10 is fairly valued even without FDA granted.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.